RxDoctor Payments Data

Kevin Lee, PA

Physician Assistant · Salinas, CANPI 1306405030

Payments from drug & device makers

$12,096in general payments, 2019–2025

Across 664 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Incyte Corporation$1K
  • Johnson & Johnson$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Lilly USA, LLC$905
  • Sun Pharmaceutical Industries Inc.$808
  • plus $6K from 25 others

What the payments were for

  • Food & beverage$10,94790%
  • Education$1,14910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,096 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$199,285
Medicare patients
833
Services billed
2,962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa13$274,616
Dupixent PenDupilumab22$104,282
Tacrolimus30$6,281
Clobetasol Propionate120$4,970
Fluorouracil58$3,778
Calcipotriene12$3,141
Ketoconazole143$2,168
Fluocinonide37$1,875
Triamcinolone Acetonide134$1,621
Metronidazole31$1,189
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc33$1,083
Betamethasone Dipropionate26$1,059
Desonide17$1,016
Doxycycline Hyclate59$764
Hydroxyzine Hcl35$439

Paid to pharmacies, not to this prescriber.

Other physician assistant in Salinas

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →